An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression
PHASE2An open-label, multi-centre, Phase 2a study to evaluate the safety, tolerab...
Location
MAC Clinical Research
An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder
PHASE2An open-label, Phase 2a study to evaluate the safety, tolerability, and pha...
Location
Clerkenwell Health
BPL-003 Efficacy and Safety in Treatment Resistant Depression
PHASE2This is a Phase 2 study randomized, quadruple masked, multi-center study , ...
Location
UAB School of Public Health, Department of Health Behavior